Genotype-guided Anticoagulation

Genotype-Guided Anticoagulation is a pharmacogenomic strategy that integrates individual genetic variation, particularly in genes such as CYP2C9 and VKORC1, to optimize the dosing and selection of anticoagulant therapy, thereby improving therapeutic efficacy and minimizing adverse drug reactions.

122

Publications

9.5K

Citations

781

Authors

286

Institutions

Publications per year

2017–2026

28

Authors

781

  1. BF
    Brian F. Gage

    Washington University in St. Louis, United States

    9 publications · 2K citations

    9

    h-index

  2. MW
    Mia Wadelius

    Uppsala University, Sweden

    6 publications · 2.6K citations

    6

    h-index

  3. MP
    Munir Pirmohamed

    University of Liverpool, United Kingdom

    5 publications · 2K citations

    5

    h-index

  4. JH
    Joyce H. S. You

    Chinese University of Hong Kong, Hong Kong SAR China

    5 publications · 245 citations

    5

    h-index

  5. MW
    Mark W. Linder

    University of Louisville, United States

    4 publications · 474 citations

    4

    h-index

1–5 of 781

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 10 publications · 1.8K citations

    10

    h-index

  2. Thrombosis and Haemostasis

    7 publications · 377 citations

    7

    h-index

  3. Pharmacogenetics and Genomics

    6 publications · 322 citations

    6

    h-index

  4. European Journal of Clinical Pharmacology

    6 publications · 348 citations

    6

    h-index

  5. PubMed

    Repository · 6 publications · 86 citations

    6

    h-index

1–5